0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmapoint crohn s disease global drug forecast market analysis 2022.Your search for "" gave back 1533059 results.
Entyvio (vedolizumab) is a prescription drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
June 2022
Price: USD 3,500.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
